Patient-specific spine implant earns another breakthrough device designation

Carlsmed received its second FDA breakthrough device designation for Aprevo, the medtech company said Sept. 20.

Advertisement

The designation is for patients with cervical spine disease, according to a news release. Aprevo devices are designed specific to each patient and is designed for spinal fusions.

“Maintenance of sagittal balance after anterior cervical discectomy and fusion procedures is an important parameter to reduce risk for subsequent degeneration at adjacent levels,” spine surgeon Christopher Ames, MD, said in the release. “Using Aprevo personalized interbody devices in conjunction with careful preoperative planning for cervical procedures may help surgeons more reliably achieve the optimal alignment for each individual patient.”

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.